The 4K Score is a blood-based test that estimates the risk of clinically significant prostate cancer (Grade Group ≥2, GG2 + ) by combining four kallikrein markers with clinical variables. However, ...

Serum Prostate Specific Antigen (PSA), considered as an important marker predicting prostate malignancy, has been clinically applied for prostate cancer screening and risk evaluation as well as follow ...

The clinical outcome of second generation anti-hormonal therapy in patients with metastatic castrate-resistant prostate cancer following CHAARTED regimen. This is an ASCO Meeting Abstract from the ...

In the wake of more than a decade of controversy over PSA testing, research is emerging that points to new approaches for the stratification of prostate cancer risk. Two noninvasive tests — an ...

Automated prostate lesion detection and PI-RADS assessment with deep learning. The relative contributions of the Genomic Prostate Score and comorbidity profile in predicting outcomes in surgically ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

While prostate cancer is a very common diagnosis, it is a deadly disease in relatively few men. One in 6 men will develop prostate cancer during his lifetime. However, of these, only one in 10 cases ...

PSA density is strongly associated with pathological stage and biochemical-free survival after radical prostatectomy for prostate cancer, researchers conclude. In lower grade prostate cancers (biopsy ...

PSA density (PSAD) predicts pathologic upstaging following radical prostatectomy (RP) for prostate cancer, a study found. The finding suggests that PSAD may be an additional parameter that clinicians ...

are aged 50 and over and have asked your GP for a test Doctors also check your PSA level as you go through prostate cancer treatment. It can help them see how well treatment is working. Prostate ...